We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Interrupting a Molecular Signaling Pathway to Treat Prostate Cancer

By LabMedica International staff writers
Posted on 11 Jan 2017
Print article
Image: The molecular model of the protein IkappaBalpha (NF-kappaB inhibitor, alpha) (Photo courtesy of Wikimedia Commons).
Image: The molecular model of the protein IkappaBalpha (NF-kappaB inhibitor, alpha) (Photo courtesy of Wikimedia Commons).
Cancer researchers have traced a molecular pathway that is active in treatment resistant prostate cancer and have suggested therapeutic strategies to circumvent it.

Androgen deprivation therapy is the most effective treatment for advanced prostate cancer, but almost all cancer eventually becomes castration resistant, and the underlying mechanisms are largely unknown. Investigators at The Scripps Research Institute (Juptier, FL, USA) recently identified one of these mechanisms.

They investigators reported in the December 29, 2016, online edition of the journal Molecular Cell that an intrinsic constitutively activated feedforward signaling circuit was formed during the emergence of castration-resistant prostate cancer (CRPC). This signaling pathway comprised the microRNA miR-196b-3p and the proteins IkappaBalpha (NF-kappaB inhibitor, alpha)/NF-kappaB (nuclear factor of kappa light polypeptide gene enhancer in B-cells), Meis2 (Homeobox protein Meis2), and PPP3CC (protein phosphatase 3 catalytic subunit gamma).

NF-kappaB inhibitor, alpha is one member of a family of cellular proteins that function to inhibit the NF-kappaB transcription factor. IkappaBalpha inhibits NF-kappaB by masking the nuclear localization signals of NF-kappaB proteins and keeping them sequestered in an inactive state in the cytoplasm. In addition, IkappaBalpha blocks the ability of NF-kappaB transcription factors to bind to DNA, which is required for NF-kappaB's proper functioning. Inactivation of the IkappaBalpha protein causes NF-kappaB to be chronically active in tumor cells and this activity contributes to the malignant state of these tumor cells.

The use of NF-kappaB inhibitors in treating cancer is complicated by severe side effects related to immunosuppression caused by indiscriminate inhibition of NF-kappaB in normal immune cells. However, the investigators suggested that targeting the other non-IkappaBalpha/NF-kappaB components in this signaling circuit would avoid the suppression of NF-kappaB in normal immune cells while keeping the potent anti-cancer efficacy.

"Disrupting this circuit by targeting any of its individual components blocks the expression of these transcription factors and significantly impairs therapy-resistant prostate cancer," said first author Dr. Ji-Hak Jeong, a research associate at The Scripps Research Institute.

Related Links:
The Scripps Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.